MESO vs. SMR
MESO (Mesoblast Limited) and SMR (Nuscale Power Corp) are both stocks. MESO operates in Biotechnology (Healthcare), while SMR operates in Specialty Industrial Machinery (Industrials). Over the past 5 years, MESO returned 0.11%/yr vs 4.24%/yr for SMR. At a 0.17 correlation, their price movements are largely independent.
Performance
MESO vs. SMR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MESO achieves a -19.51% return, which is significantly lower than SMR's -13.41% return.
MESO
- 1D
- 0.00%
- 1M
- -9.25%
- YTD
- -19.51%
- 6M
- -14.24%
- 1Y
- 37.63%
- 3Y*
- 25.99%
- 5Y*
- 0.11%
- 10Y*
- 0.27%
SMR
- 1D
- -12.04%
- 1M
- 0.74%
- YTD
- -13.41%
- 6M
- -39.08%
- 1Y
- -61.40%
- 3Y*
- 16.95%
- 5Y*
- 4.24%
- 10Y*
- —
MESO vs. SMR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
MESO Mesoblast Limited | -19.51% | -8.89% | 800.00% | -62.20% | -39.37% | -43.46% | -50.03% |
SMR Nuscale Power Corp | -13.41% | -20.97% | 444.98% | -67.93% | 2.29% | -0.89% | 1.71% |
Correlation
The correlation between MESO and SMR is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Dec 10, 2020 | 0.17 |
Fundamentals
MESO:
-$0.80
SMR:
-$2.02
MESO:
107.50
SMR:
129.54
MESO:
$17.20M
SMR:
$18.10M
MESO:
-$35.86M
SMR:
$4.45M
MESO:
-$58.18M
SMR:
-$696.20M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MESO vs. SMR — Risk / Return Rank
MESO
SMR
MESO vs. SMR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Mesoblast Limited (MESO) and Nuscale Power Corp (SMR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MESO | SMR | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.58 | -0.59 | +1.18 |
Sortino ratioReturn per unit of downside risk | 1.29 | -0.61 | +1.90 |
Omega ratioGain probability vs. loss probability | 1.16 | 0.94 | +0.22 |
Calmar ratioReturn relative to maximum drawdown | 1.09 | -0.74 | +1.83 |
Martin ratioReturn relative to average drawdown | 2.04 | -1.10 | +3.14 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MESO | SMR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.58 | -0.59 | +1.18 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.00 | 0.05 | -0.04 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.00 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.01 | 0.04 | -0.05 |
Drawdowns
MESO vs. SMR - Drawdown Comparison
The maximum MESO drawdown since its inception was -95.66%, which is greater than SMR's maximum drawdown of -87.47%. Use the drawdown chart below to compare losses from any high point for MESO and SMR.
Loading charts...
Drawdown Indicators
| MESO | SMR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.66% | -87.47% | -8.19% |
Max Drawdown (1Y)Largest decline over 1 year | -34.71% | -82.86% | +48.15% |
Max Drawdown (3Y)Largest decline over 3 years | -82.19% | -82.86% | +0.67% |
Max Drawdown (5Y)Largest decline over 5 years | -89.99% | -87.47% | -2.52% |
Max Drawdown (10Y)Largest decline over 10 years | -95.66% | — | — |
Current DrawdownCurrent decline from peak | -63.35% | -77.04% | +13.69% |
Average DrawdownAverage peak-to-trough decline | -59.01% | -34.87% | -24.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.53% | 55.79% | -37.26% |
Volatility
MESO vs. SMR - Volatility Comparison
The current volatility for Mesoblast Limited (MESO) is 10.97%, while Nuscale Power Corp (SMR) has a volatility of 30.10%. This indicates that MESO experiences smaller price fluctuations and is considered to be less risky than SMR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MESO | SMR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.97% | 30.10% | -19.13% |
Volatility (6M)Calculated over the trailing 6-month period | 37.97% | 69.57% | -31.60% |
Volatility (1Y)Calculated over the trailing 1-year period | 64.73% | 103.97% | -39.24% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 85.86% | 93.22% | -7.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 95.03% | 89.27% | +5.76% |
Dividends
MESO vs. SMR - Dividend Comparison
Neither MESO nor SMR has paid dividends to shareholders.
Financials
MESO vs. SMR - Financials Comparison
This section allows you to compare key financial metrics between Mesoblast Limited and Nuscale Power Corp. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MESO and SMR have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SMR has higher volatility (30.10%) compared to MESO (10.97%). In terms of maximum drawdown, MESO dropped -95.66% vs SMR's -87.47%.
MESO currently has the higher Sharpe Ratio (0.58 vs -0.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MESO and SMR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer